Phase I trial of PulmoXen™ in healthy volunteers

Trial Profile

Phase I trial of PulmoXen™ in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 09 Apr 2014

At a glance

  • Drugs Dornase alfa (Primary)
  • Indications Cystic fibrosis
  • Focus Adverse reactions
  • Sponsors Pharmasyntez
  • Most Recent Events

    • 09 Apr 2014 New trial record
    • 07 Apr 2014 Safety data from a completed phase I trial were presented in a Xenetic Biosciences media release.
    • 17 Jul 2013 Phase I trial was to be initiated in the third quarter of 2013, according to a Pharmsynthez media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top